These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2299784)

  • 1. Bromide intoxication secondary to pyridostigmine bromide therapy.
    Rothenberg DM; Berns AS; Barkin R; Glantz RH
    JAMA; 1990 Feb; 263(8):1121-2. PubMed ID: 2299784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
    Faradji-Hazan V; Oster JR; Fedeman DG; Clerch AR; Perez GO
    J Am Soc Nephrol; 1991 Mar; 1(9):1123-5. PubMed ID: 1912410
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis.
    Kaplan F; Topal E
    Turk J Pediatr; 2023; 65(2):326-329. PubMed ID: 37114698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pyridostigmine mixture in the treatment of myasthenia gravis].
    Behrens JK
    Ugeskr Laeger; 1992 Feb; 154(8):508. PubMed ID: 1539384
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical therapy for oropharyngeal symptoms of myasthenia gravis.
    Dooley JM; Goulden KJ; Gatien JG; Gibson EJ; Brown BS
    Ann Neurol; 1986 Feb; 19(2):192-4. PubMed ID: 3963762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis.
    Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Augusto MejíA-Vélez C
    Muscle Nerve; 2017 Dec; 56(6):1041-1046. PubMed ID: 28214292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of pyridostigmine induced parkinsonism].
    Iwasaki Y; Kinoshita M; Wakata N
    Rinsho Shinkeigaku; 1988 Jun; 28(6):662-4. PubMed ID: 3233838
    [No Abstract]   [Full Text] [Related]  

  • 9. Steady state kinetics of pyridostigmine in myasthenia gravis.
    Sørensen PS; Flachs H; Friis ML; Hvidberg EF; Paulson OB
    Neurology; 1984 Aug; 34(8):1020-4. PubMed ID: 6540381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.
    Aquilonius SM; Eckernäs SA; Hartvig P; Lindström B; Osterman PO; Stålberg E
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):929-35. PubMed ID: 6644317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of myasthenia gravis].
    Janda A; Brandstetter A
    Dtsch Med Wochenschr; 1986 Jul; 111(27):1081-2. PubMed ID: 3720565
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.
    Breyer-Pfaff U; Schmezer A; Maier U; Brinkmann A; Schumm F
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):502-6. PubMed ID: 2166138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis due to bromide intoxication.
    Stern J
    N Y State J Med; 1966 Nov; 66(21):2818-23. PubMed ID: 5232158
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of chronic pyridostigmine administration on pyridostigmine-14C metabolism in myasthenia gravis.
    Kornfeld P; Wolf RL; Samuels AJ; Osserman KE
    Neurology; 1971 May; 21(5):550-2. PubMed ID: 5104099
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma pyridostigmine levels in patients with myasthenia gravis.
    Calvey TN; Chan K
    Clin Pharmacol Ther; 1977 Feb; 21(2):187-93. PubMed ID: 837637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.
    Singh G; Hodgson T; Clarke DE
    Perm J; 2017; 21():15-240. PubMed ID: 28080955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pyridostigmine levels in myasthenia gravis.
    White MC; De Silva P; Havard CW
    Neurology; 1981 Feb; 31(2):145-50. PubMed ID: 7193298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlooked myasthenia gravis in an elderly adult.
    Jiang L; Wu W; Guan W; Wu Z; Nie Y
    J Am Geriatr Soc; 2013 May; 61(5):840-1. PubMed ID: 23672558
    [No Abstract]   [Full Text] [Related]  

  • 20. Malabsorption of pyridostigmine in patients with myasthenia gravis.
    Cohan SL; Dretchen KL; Neal A
    Neurology; 1977 Mar; 27(3):299-301. PubMed ID: 557769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.